Naldebain and Video-assisted Thoracoscopic Surgery

Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Jul 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called Naldebain® when used with a specific pain relief technique known as a thoracic paravertebral block during video-assisted thoracoscopic surgery. The goal is to see how well this combination can help reduce pain after surgery, making patients feel more comfortable and satisfied with their care.

To participate in this trial, you need to be between 20 and 65 years old and require pain relief after thoracoscopic surgery. However, certain individuals cannot participate, such as those with serious heart or lung issues, pregnant women, or those who have had chronic pain or drug allergies related to Naldebain. If you join the study, you can expect to receive close monitoring and support as part of your recovery process, and you'll be contributing to important research that could help improve pain management for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) Subject's age: 20\~65 years old
• • 2) American Society of Anesthesiologists (ASA) Physical Status classification: I\~III
• • 3) Patients who need postoperative pain relief due to thoracoscopic surgery
• Exclusion Criteria:
• • 1. The patient suffers from a communication disorder
• • 2. The patient has coagulopathy
• • 3. Sick with obvious heart, lung, liver or kidney disease
• • 4. The patient's body mass index is less than 18.5 or greater than 35
• • 5. Pregnant patients
• • 6. Patients who took opioids for more than three weeks before surgery
• • 7. Patients with contraindications to local anesthesia
• • 8. Patients with a history of chronic pain
• • 9. Patients with a history of drug allergy to Naldebain